Identification and characterization of early growth response 2, a zinc-finger transcription factor, as a p53-regulated proapoptotic gene

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1407-1416

  Yokota, Ikuko ^a   Sasaki, Yasushi ^a   Kashima, Lisa ^a   Idogawa, Masashi ^a   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Early growth response 2; p53; p53 family; p63; p73

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; MESSENGER RNA; PROTEIN P53; PROTEIN P63; PROTEIN P73;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; DNA DAMAGE; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 2; GENE EXPRESSION REGULATION; HCT116 CELLS; HELA CELLS; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RATS; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; ZINC FINGERS;

EID: 78649967704     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000792     Document Type: Article

References (39)

1. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408: 307-310, 2000.
2. Tokino T and Nakamura Y: The role of p53-target genes in human cancer. Crit Rev Oncol Hematol 33: 1-6, 2000. (Pubitemid 30064481)
3. el-Deiry WS: Regulation of p53 downstream genes. Semin Cancer Biol 8: 345-357, 1998.
4. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1: 45-49, 1992.
5. el-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
6. Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299, 1995.
7. Oda E, Ohki R, Murasawa H, et al: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000.
8. Oda K, Arakawa H, Tanaka T, et al: P53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 102: 849-862, 2000.
9. Nakano K and Vousden KH: Puma, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694, 2001.
10. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B: Puma induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682, 2001. (Pubitemid 32706358)
11. Owen-Schaub LB, Zhang W, Cusack JC, et al: Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15: 3032-3040, 1995.
12. Wu GS, Burns TF, McDonald ER 3rd, et al: KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17: 141-143, 1997.
13. Hagiwara K, McMenamin MG, Miura K and Harris CC: Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 59: 4165-4169, 1999. (Pubitemid 29418718)
14. Irwin MS and Kaelin WG: p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 12: 337-349, 2001.
15. Flores ER, Sengupta S, Miller JB, et al: Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7: 363-373, 2005. (Pubitemid 40544653)
16. Sasaki Y, Negishi H, Koyama R, et al: p53 family members regulate the expression of the apolipoprotein D gene. J Biol Chem 284: 872-883, 2009.
17. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R and Charnay P: A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J 7: 29-35, 1988.
18. Unoki M and Nakamura Y: Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 20: 4457-4465, 2001.
19. Unoki M and Nakamura Y: Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity. FEBS Lett 554: 67-72, 2003.
20. Morimoto I, Sasaki Y, Ishida S, Imai K and Tokino T: Identification of the osteopontin gene as a direct target of TP53. Genes Chromosomes Cancer 33: 270-278, 2002.
21. Ishida S, Yamashita T, Nakaya U and Tokino T: Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Jpn J Cancer Res 91: 174-180, 2000. (Pubitemid 30130747)
22. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K and Tokino T: Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: Potential application to gene therapy of colorectal cancer. Gene Ther 8: 1401-1408, 2001. (Pubitemid 32895671)
23. O'Donovan KJ, Tourtellotte WG, Millbrandt J and Baraban JM: The EGR family of transcription-regulatory factors: Progress at the interface of molecular and systems neuroscience. Trends Neurosci 22: 167-173, 1999.
24. Beckmann AM and Wilce PA: Egr transcription factors in the nervous system. Neurochem Int 31: 477-510-517, 1997.
25. Thiel G and Cibelli G: Regulation of life and death by the zinc finger transcription factor EGR-1. J Cell Physiol 193: 287-292, 2002. (Pubitemid 35265949)
26. Yang SZ, Eltoum IA and Abdulkadir SA: Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment. J Cell Biochem 97: 1292-1299, 2006.
27. Schnell FJ, Zoller AL, Patel SR, Williams IR and Kersh GJ: Early growth response gene 1 provides negative feedback to inhibit entry of progenitor cells into the thymus. J Immunol 176: 4740-4747, 2006.
28. Laslo P, Spooner CJ, Warmflash A, et al: Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126: 755-766, 2006.
29. Droin NM, Pinkoski MJ, Dejardin E and Green DR: EGR family members regulate nonlymphoid expression of fas ligand, trail, and tumor necrosis factor during immune responses. Mol Cell Biol 23: 7638-7647, 2003.
30. Xiao D, Chinnappan D, Pestell R, Albanese C and Weber HC: Bombesin regulates cyclin D1 expression through the early growth response protein EGR-1 in prostate cancer cells. Cancer Res 65: 9934-9942, 2005.
31. Ihrie RA, Marques MR, Nguyen BT, et al: Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856, 2005.
32. Yang A, Walker N, Bronson R, et al: p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103, 2000. (Pubitemid 30143141)
33. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713, 1999. (Pubitemid 29197649)
34. Celli J, Duijf P, Hamel BC, et al: Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99: 143-153, 1999.
35. Pareyson D, Taroni F, Botti S, et al: Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation. Neurology 54: 1696-1698, 2000.
36. Vucic S, Kennerson M, Zhu D, Miedema E, Kok C and Nicholson GA: Cmt with pyramidal features. Charcot-Marie-Tooth. Neurology 60: 696-699, 2003.
37. Houlden H and Reilly MM: Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 8: 43-62, 2006. (Pubitemid 43918165)
38. Timmerman V, De Jonghe P, Ceuterick C, et al: Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 52: 1827-1832, 1999.
39. Levi G, Topilko P, Schneider-Maunoury S, et al: Defective bone formation in Krox-20 mutant mice. Development 122: 113-120, 1996. (Pubitemid 26038423)